IndraLab

Statements

4'-epidoxorubicin inhibits NLRP3. 1 / 1

| 1

reach

"Low-dose epirubicin at non cytotoxic doses downregulated NLRP3 inflammasome components and reduced the release of cleaved caspase-1, bioactive IL-1beta, and TNF-alpha following NLRP3 activation in a dose dependent fashion."

31905600

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

4'-epidoxorubicin inhibits NLRP3. 1 / 1

INDRA sources:

Databases

Reading